New review: 1.6% of women and girls have debilitating Premenstrual Dysphoric Disorder

Around 1.6% of women and girls have symptomatic Premenstrual Dysphoric Disorder (PMDD), according to a new review of global studies.

Abridge, an AI startup for medical notes, raises $150M

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Abridge raised a Series C just four

February 24, 2024

Anakinra shows promise in reducing symptoms in patients with Sanfilippo syndrome

As a neurodegenerative disease characterized by childhood onset dementia, Sanfilippo syndrome causes immense suffering in many ways, including pain, loss of speech, extreme agitation, and

June 21, 2024

Three Important Changes in AASM’s New Restless Legs Syndrome Guidelines

The American Academy of Sleep Medicine (AASM) has updated its guidelines for the treatment of restless legs syndrome (RLS) for the first time in 12

November 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.